In Vivo Efficacy of Humanized Exposures of Cefiderocol Compared with Cefepime (FEP) and Meropenem (MEM) against Gram-negative Bacteria in a Murine Thigh Model

BACKGROUND: Cefiderocol (S-649266) is a novel siderophore cephalosporin under development by Shionogi (Osaka, Japan). Previous studies have demonstrated cefiderocol efficacy against a diverse population of Gram-negative bacteria with MICs ≤ 4 μg/mL. Our aim was to further define the agent’s clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Monogue, Marguerite, Tsuji, Masakatsu, Yamano, Yoshinori, Echols, Roger, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631164/
http://dx.doi.org/10.1093/ofid/ofx163.1216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631164/
http://dx.doi.org/10.1093/ofid/ofx163.1216

Ejemplares similares